---
title: "Miss Danielle Kunaka — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8a6ef921-dcc3-4419-895b-aef91cba617b
json: https://whiteintel.dev/api/public/dossier/8a6ef921-dcc3-4419-895b-aef91cba617b
identifier: psc:kk3JQMj9gDDnY3J-Coh7mHlVpL0
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Miss Danielle Kunaka

**Type:** Person  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:kk3JQMj9gDDnY3J-Coh7mHlVpL0`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8a6ef921-dcc3-4419-895b-aef91cba617b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8a6ef921-dcc3-4419-895b-aef91cba617b  

## Ownership & control

### Holdings / subsidiaries

- **DK PHARMACEUTICAL CONSULTANCY LTD** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/596ca181-3275-5e91-8dfe-dc6dd98224cd

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Miss Danielle Kunaka**. Human view: https://whiteintel.dev/entity/8a6ef921-dcc3-4419-895b-aef91cba617b · Structured JSON: https://whiteintel.dev/api/public/dossier/8a6ef921-dcc3-4419-895b-aef91cba617b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._